Skip to main content
MBI logo

MBI — Investor Relations & Filings

Ticker · 1783 ISIN · TW0001783009 TW Manufacturing
Open in API
Filings indexed 1,694 across all filing types
Latest filing 2024-08-06 Regulatory Filings
Country TW Taiwan
Listing TW 1783

About MBI

www.mbi.com.tw

Maxigen Biotech Inc. (MBI) is a medical device manufacturer specializing in the research, development, and production of biopolymer-based solutions, primarily focusing on collagen matrix and hyaluronic acid technologies. The company provides a comprehensive range of medical devices across multiple clinical disciplines, including orthopedics, aesthetics, ophthalmology, and wound care. Key products include hyaluronic acid intra-articular injections, dermal fillers, ophthalmic viscoelastics, collagen wound dressings, dental membranes, and synthetic bone grafts. In addition to its proprietary brands, MBI offers global OEM/ODM and customization services. The company adheres to international quality standards, holding certifications such as CE, FDA, NMPA, and MDSAP. MBI leverages its expertise in biopolymer science to deliver innovative medical and skincare products to international markets.

Recent filings

Filing Released Lang Actions
113年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts, investment methods, and related financial figures concerning investments in mainland China by the company 和康生. It includes specific financial data such as capital amounts, investment gains/losses, and regulatory approval limits. The document is relatively short (1302 characters) and focuses on investment details rather than a full financial report or announcement. It does not appear to be an announcement of a report publication, nor a certification or a brief summary. The content aligns with a regulatory disclosure related to investment activities, which typically falls under Regulatory Filings (RNS) as it does not fit the definitions of other specific categories like Annual Report, Interim Report, or Capital/Financing Update. Therefore, the best classification is Regulatory Filings (RNS).
2024-08-06 Chinese
113年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 和康生, providing information on fund lending balances and endorsement guarantees for the current and previous month. It contains tabulated financial data but is very short (612 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure or compliance update rather than a full financial report or announcement of a meeting or vote. There is no indication of an annual or interim report, earnings release, or management discussion. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-05 Chinese
113年7月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative revenue figures for a company named 和康生, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or audit information. The length is short (766 characters), and it is a straightforward revenue summary without any indication of being a full financial report or an announcement of a report publication. This type of document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data without the depth or format of an Interim Report or Annual Report.
2024-08-05 Chinese
113年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for the current and previous half-year periods (民國113年上半年度 and 民國112年上半年度). The data includes components such as common stock, capital surplus, retained earnings, and other equity items, which are typical elements of a comprehensive financial report. The presence of half-year period data and detailed financial figures indicates this is a substantive financial report for a period shorter than a full fiscal year. The document length is 4523 characters, which is sufficient to contain actual financial data rather than just an announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-07-29 Chinese
113年第2季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the second quarter of the 113th year (which corresponds to 2024) and the same period in the previous year. It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific monetary amounts. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 2205 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-07-29 Chinese
113年第2季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed consolidated income statement data for the second quarter and half-year periods of the fiscal year 113 (which corresponds to 2024 in the Taiwanese calendar). It includes comprehensive financial figures such as revenue, costs, gross profit, operating expenses, net income, earnings per share, and other detailed financial metrics. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year (quarter and half-year) indicates this is a financial report for an interim or quarterly period. The document length is 3444 characters, which is sufficient to contain actual financial data rather than just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-07-29 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.